Rockefeller Capital Management’s Cardiff Oncology CRDF Stock Holding History

Rockefeller Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$91.5K	Hold	56,500	–	–	﹤0.01%	2929
2025 Q4	$159K	Sell	56,500 -6,000	-10%	-$13.9K	﹤0.01%	2485
2025 Q3	$129K	Buy	+62,500	New	+$173K	﹤0.01%	2445
2022 Q4	–	Sell	-163	Closed	–	–	3894
2022 Q3	$0	Hold	163	–	–	﹤0.01%	3949
2022 Q2	$0	Buy	163 +156	+2,229%	+$261	﹤0.01%	4140
2022 Q1	$0	Buy	7 +1	+17%	+$4	﹤0.01%	3893
2021 Q4	$0	Buy	+6	New	+$36	﹤0.01%	3799
2021 Q3	–	Sell	-882	Closed	-$5K	–	3709
2021 Q2	$5K	Sell	882 -353	-29%	-$2.99K	﹤0.01%	3022
2021 Q1	$11K	Buy	1,235 +1,061	+610%	+$12.9K	﹤0.01%	2535
2020 Q4	$3K	Sell	174 -6,880	-98%	-$121K	﹤0.01%	2546
2020 Q3	$100K	Buy	+7,054	New	+$46.6K	﹤0.01%	1253

Other funds holding CRDF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Rockefeller Capital Management's CRDF Position: Q1 2026 in Review

Rockefeller Capital Management held its Cardiff Oncology (CRDF) position steady in Q1 2026 at 56,500 shares worth $91.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2929.

Rockefeller Capital Management first reported a position in CRDF in Q3 2020 and has held it in 11 quarters since. The position peaked at $159K in Q4 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

Rockefeller Capital Management held 56,500 shares of Cardiff Oncology worth $91.5K as of Q1 2026.
Rockefeller Capital Management left its Cardiff Oncology share count unchanged in Q1 2026.
Cardiff Oncology made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2929 holding.
Rockefeller Capital Management first reported a position in Cardiff Oncology in Q3 2020 and has held it in 11 quarters since.
Rockefeller Capital Management's Cardiff Oncology position peaked at $159K in Q4 2025.
116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.